Clinical Trials Logo

Ankylosing Spondylitis clinical trials

View clinical trials related to Ankylosing Spondylitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06226792 Completed - Clinical trials for Ankylosing Spondylitis

Muscle Architecture in Ankylosing Spondylitis

Start date: January 18, 2024
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to determine whether there is a decrease in muscle mass and the relationship between lower extremity skeletal muscle mass, muscle strength and disease activity in Ankylosing spondylitis. The main questions it aims to answer are: - Is there a relationship between the muscle thickness and pennation angle of the quadriceps, Gastrocnemius medialis and lateralis, Vastus medialis and lateralis and tibialis anterior muscles with disease activity and muscle strength? - Are there any differences in the results of morphological parameters of lower extremity muscles between Ankylosing spondylitis and voluntary participants? Researchers will compare voluntary participants to see if any difference in lower muscle morphological parameters.

NCT ID: NCT06185712 Completed - Clinical trials for Ankylosing Spondylitis

Patient Education in Ankylosing Spondylitis

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

This study was carried out to investigate the effect of a nurse-led disease management education program in AS on patient compliance, disease activity, functional capacity, kinesiophobia, and quality of life. A total of 122 patients diagnosed with AS according to the modified New York criteria were included in the study. The intervention group received nurse-led individualized disease management education. In the control group, no interventions were performed other than routine clinical procedures.

NCT ID: NCT06094686 Completed - Clinical trials for Ankylosing Spondylitis

Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis

Start date: August 1, 2015
Phase:
Study type: Observational

The aim of this study was to assess the EATT and the related factors in patients with AS and to compare the results with that of the healthy controls'

NCT ID: NCT06094673 Completed - Clinical trials for Ankylosing Spondylitis

The Relationship Between Systemic Immune Inflammation Index and Disease Activity in Patients With Ankylosing Spondylitis

Start date: June 1, 2023
Phase:
Study type: Observational [Patient Registry]

In this study, the aim was to investigate the relationship between SII and other laboratory parameters with disease activity in AS patients and to discuss its usability in the follow-up and treatment process.

NCT ID: NCT06085534 Completed - Clinical trials for Ankylosing Spondylitis

A Study of LNK01001 Capsule in Patients With Ankylosing Spondylitis

Start date: January 6, 2022
Phase: Phase 2
Study type: Interventional

The objective of this study was to evaluate the safety and efficacy of multiple doses of LNK01001 monotherapy versus placebo in the treatment of adults with active Ankylosing Spondylitis

NCT ID: NCT05987111 Completed - Clinical trials for Ankylosing Spondylitis

Pilates in Ankylosing Spondylitis

Start date: August 2, 2022
Phase: N/A
Study type: Interventional

This study was planned to examine and compare the effectiveness of two different pilates exercise methods (mat pilates vs reformer pilates) in individuals with Ankylosing Spondylitis(AS).

NCT ID: NCT05839925 Completed - Clinical trials for Ankylosing Spondylitis

Prevalence of Temporomandibular Joint Dysfunction in Patients With Ankylosing Spondylitis

Start date: April 1, 2022
Phase:
Study type: Observational

This study included 113 patients diagnosed with ankylosing spondylitis and 110 healthy volunteers. Participants in both groups were evaluated using the 'Diagnostic Criteria for Temporomandibular Disorders (DC/TMD)' diagnostic criteria. In addition, the relationship between temporomandibular joint dysfunction and disease activity was investigated in patients with ankylosing spondylitis.

NCT ID: NCT05771376 Completed - Clinical trials for Ankylosing Spondylitis

The Effects of Baduanjin Qigong Exercise on Ankylosing Spondylitis: A Randomized Controlled Study

Start date: February 13, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to examine the effectiveness of 12-week Baduanjin qigong exercises in patients with ankylosing spondylitis. 59 volunteer individuals, ages 18-64, will be included in the study. They will be randomly divided into two groups (the intervention and the control). The intervention group will perform a qigong exercise program online (via Zoom video conference) for 12 weeks under the supervision of two physiotherapists. The qigong exercise program had previously been videotaped by the researchers. The control group will perform the home exercise program at home for 12 weeks.

NCT ID: NCT05589922 Completed - Clinical trials for Ankylosing Spondylitis

The Relationship Between Abnormal Modified Schober Index and Demographic Characteristics and Clinical Variables

Start date: October 24, 2022
Phase:
Study type: Observational

This study will aim to compare ankylosing spondylitis (AS) participants with abnormal modified Schober index (AMSI) versus AS participants with normal modified Schober index (NMSI) in pain, morning stiffness, balance, kinesiophobia and the fear of falling. In addition, the investigators will aim to determine which demographic characteristics and variables predispose AMSI to occur

NCT ID: NCT05570656 Completed - Clinical trials for Ankylosing Spondylitis

Modeling Spinal Mobility in Ankylosing Spondylitis: Towards New Telekinetic Biomarkers

TELESPA
Start date: December 13, 2022
Phase: N/A
Study type: Interventional

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease that mainly affects the spine and pelvis in its axial form. It is responsible for chronic inflammatory pain and sometimes ankylosis with significant functional retention. Clinicians need markers capable of precisely measuring the restriction of range of motion in these patients, reflections of the activity and/or sequelae of the disease. The Inverstigators validated movement markers in the AS by a device including inertial sensors (XSENS) and computer modeling. The accuracy and repeatability of the XSENS-Awinda system compared to the reference measurement system have been demonstrated. The XSENS-Awinda device offers new real-time evaluation possibilities for quantitative gait analysis. This opens the way to new diagnostic tools, prognostics and therapeutic perspectives for the clinician.